Home > Products > CD2 & EGFR
> Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (scDiabody-Fc)
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (scDiabody-Fc) (CAT#: SCDBF-046)
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (scDiabody-Fc) is a fusion protein of two scDiabodies with an Fc region. In single-chain Diabodies, an additional connecting linker is introduced between chains of the anti-CD2/anti-EGFR diabody. The scDiabody with two specificities is further fused to the Fc domain to form BsAb with 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.
Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors
There are currently no customer reviews or questions for Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (scDiabody-Fc) (SCDBF-046). Click the button below to contact us or submit your feedback about this product.